Navigation Links
Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma

ng resistance mediated by Mcl-1 also reveals the breadth of the compound's therapeutic potential. These findings suggest that Gemin X's obatoclax (GX15-070) in combination with bortezomib may prove to be an attractive new approach in the treatment of MCL, and further support our recent initiation of this combination in a Phase 1b trial in MCL."

Gemin X is currently conducting several clinical trials of obatoclax (GX15-070) in multiple cancer types as a combination therapy and as a single agent. In addition to the Phase 1b trial in MCL, Gemin X recently initiated a Phase 1/2 clinical trial in combination with docetaxel in patients with non-small cell lung cancer. Obatoclax (GX15-070) is also in Phase 2 clinical trials in patients with Hodgkin's Lymphoma, myelofibrosis with myeloid metaplasia, myelodysplastic syndrome, and follicular lymphoma both as single agent and in combination with rituximab. In multiple Phase 1 studies, obatoclax (GX15-070) was well-tolerated and resulted in clinical and biological activity.

About Mantle Cell Lymphoma (MCL)

Mantle cell lymphoma (MCL) belongs to a group of diseases known as non-Hodgkin's lymphomas, which are related cancers that affect the lymphatic system. Mantle cell lymphoma is an aggressive B-cell lymphoma that historically has been resistant to current standard chemotherapeutic approaches, making it a difficult cancer to treat. The median survival time is three years and the ten-year survival rate is only 5-10%.

Gemin X Biotechnologies Inc. specializes in the discovery and development of novel small molecule cancer therapeutics based on the regulation of apoptosis, the body's natural ability to destroy injured or damaged cells. Gemin X's lead product, obatoclax (GX15-070), is a small molecule, pan-inhibitor of Bcl-2 pro-survival proteins and is currently in Phase 2 clinical trials. Gemin X is also developing a small molecule that induces apoptosis in p53-defective cancers. Gemin X is privately hel
'"/>




Page: 1 2 3

Related medicine technology :

1. Gemin X Presents Positive Preclinical Data of GX15-070 in Infant ALL at AACR Meeting
2. Gemin X Announces Publication of Preclinical Data of GX15-070 in Multiple Myeloma in Blood
3. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
4. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:8/29/2014)... 29, 2014  A Boston Scientific Corporation (NYSE: ... stent removability and preliminary long term stricture resolution ... the August issue of the peer-reviewed journal, Gastroenterology. ... is being conducted in 11 countries and five ... metal stents (FCSEMS) after extended indwell (i.e., up ...
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... , Aug. 29, 2014 Medina Medical announced ... and member of the Board of Directors on August ... device development and commercialization experience, including over a decade ... previously served as a Partner of the medical device ... CEO of two Foundry start-ups. Mr. Engelson previously served ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... Pharmaceuticals, Inc. (Nasdaq: JAZZ ) announced today that ... upcoming investor conferences:   Kathryn Falberg, the ... ROTH 23rd Annual OC Growth Stock Conference in Dana Point, ... Time Bruce Cozadd, the company,s chairman and chief executive ...
... DUBLIN, March 8, 2011 Warner Chilcott plc (Nasdaq: ... of 25 million of its ordinary shares by certain ... Bain Capital Partners, J.P. Morgan Partners (advised by CCMP ... of the Company,s senior management. The offering is being ...
Cached Medicine Technology:Warner Chilcott Announces Secondary Equity Offering 2Warner Chilcott Announces Secondary Equity Offering 3Warner Chilcott Announces Secondary Equity Offering 4
(Date:8/29/2014)... (PRWEB) August 29, 2014 Dr. Parsa Mohebi ... stages of hair loss achieve great results in hair transplantation. ... Facial Hair Transplant , an FUE method that harvests facial ... This method lets patients whose hair loss classification is ... Hair Transplant is a great alternative for those advanced hair ...
(Date:8/29/2014)... Mar, CA (PRWEB) August 29, 2014 A ... bra,” a bra developed by a Tokyo clothing store for ... in the hopes of rectifying or diminishing their problem. Board-certified ... treated men with the problem. While many people only associate ... actually a fairly common condition among men of all ages, ...
(Date:8/29/2014)... 29, 2014 Healthpointe is pleased ... Physical Therapy students via Clinical Rotations. ... be shadowing Healthpointe providers and specialists throughout their ... develop clinical experience and learn professional preparation. ... gain insight into several patient care techniques and ...
(Date:8/29/2014)... 2014 Highly regarded audiologist , Dr. Mary ... health topics. The four reports are titled:, , ... Hearing Aid Success , The Top 5 Things You ... Auditory Processing Disorder in Children , Dr. Mary Anne ... a lot of confusion and misinformation about each them. The ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Astronauts ... travel appears to disrupt human immune systems, a new ... on any long missions to asteroids, the moon and ... or flu while in space can be dangerous, NASA ... immune cells in the blood of International Space Station ...
Breaking Medicine News(10 mins):Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 2Health News:New Bra Created for Men with Gynecomastia, But Will It Work? 3Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2
... the genetic variations in detoxifying enzymes for developing Lou ... genetic variations in three enzymes, which are used to ... for metabolising cholesterol lowering, statin drugs might be a ... or Lou Gehrig's disease). The study also indicates that ...
... failing to implement rules that will reduce the risk ... instruments. ,The report said that surgical teams ... be traced easily. Instead kits are being swapped for ... executive of the NHS Confederation, said it was vital ...
... of health has expressed concern about the rise in the ... increase in the number of girls under the age of ... and depression. According to the Bureau of Health Promotion ... smoke regularly. , Deputy Director of the health ...
... NSW, daycare centers are planning to phase out junk food ... up by the Health Department to counter childhood obesity//. ... drinks, even as they were being sent to dieticians. ... two to five-year-olds, is the biggest study of its kind ...
... The Hyderabad-based Aurobindo Pharma Ltd today said it has ... Jersey//. ,The facility, spread over 20 acres of ... quarters, it informed the stock exchanges. ,"This purchase ... effective manner," Ramprasad Reddy, Chairman of the company, said. ...
... A 62-year-old child psychiatrist has become Britain’s oldest mother ... that Patti Farrant, professionally known as Patricia Rashbrook, gave ... born at the Royal Sussex County Hospital in Brighton, ... is already a mother to three grown-up children from ...
Cached Medicine News:Health News:Genetic Variations In Detoxifying Genes Lead To Lou Gehrig's diseases 2
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... The Vidiera NsD Nucleic Sample Detection ... acids, post amplification. The new platform ... by capillary electrophoresis (CE), with software features ... and flexibility. Vidiera NsD has the ...
Invacare 5 Oxygen Concentrator, 230 VAC - Intl....
... PLUS CONCENTRATOR ANALYZER Now there is one ... parameters necessary for performing concentrator checks. Introducing ... efficient and cost-effective analyzer designed with technicians ... flow rate (L-min), and patient outlet pressure ...
Medicine Products: